Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.

Sala-Icardo L, Lamana A, Ortiz AM, García Lorenzo E, Moreno Fresneda P, García-Vicuña R, González-Álvaro I.

Reumatol Clin. 2016 Oct 14. pii: S1699-258X(16)30101-2. doi: 10.1016/j.reuma.2016.08.006. [Epub ahead of print] English, Spanish.

2.

Influence of patient personality in the treatment of rheumatoid arthritis.

Leon L, Redondo M, Garcia-Vadillo A, Perez-Nieto MA, Rodriguez-Rodriguez L, Jover JA, Gonzalez-Alvaro I, Abasolo L.

Rheumatol Int. 2016 Nov;36(11):1549-1555.

PMID:
27614619
3.

Urine metabolome profiling of immune-mediated inflammatory diseases.

Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S; IMID Consortium..

BMC Med. 2016 Sep 8;14(1):133. doi: 10.1186/s12916-016-0681-8.

4.

Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis.

González-Álvaro I, Castrejón I, Ortiz AM, Toledano E, Castañeda S, García-Vadillo A, Carmona L; EMECAR Study Group..

PLoS One. 2016 Sep 7;11(9):e0161727. doi: 10.1371/journal.pone.0161727.

5.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

6.

Comparative analysis of EV isolation procedures for miRNAs detection in serum samples.

Andreu Z, Rivas E, Sanguino-Pascual A, Lamana A, Marazuela M, González-Alvaro I, Sánchez-Madrid F, de la Fuente H, Yáñez-Mó M.

J Extracell Vesicles. 2016 Jun 20;5:31655. doi: 10.3402/jev.v5.31655.

7.

A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.

Márquez A, Vidal-Bralo L, Rodríguez-Rodríguez L, González-Gay MA, Balsa A, González-Álvaro I, Carreira P, Ortego-Centeno N, Ayala-Gutiérrez MM, García-Hernández FJ, González-Escribano MF, Sabio JM, Tolosa C, Suárez A, González A, Padyukov L, Worthington J, Vyse T, Alarcón-Riquelme ME, Martín J.

Ann Rheum Dis. 2016 May 18. pii: annrheumdis-2016-209436. doi: 10.1136/annrheumdis-2016-209436. [Epub ahead of print]

PMID:
27193031
8.

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.

Ortea I, Roschitzki B, López-Rodríguez R, Tomero EG, Ovalles JG, López-Longo J, de la Torre I, González-Alvaro I, Gómez-Reino JJ, González A.

PLoS One. 2016 Apr 6;11(4):e0153140. doi: 10.1371/journal.pone.0153140.

9.

Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.

Municio C, Soler Palacios B, Estrada-Capetillo L, Benguria A, Dopazo A, García-Lorenzo E, Fernández-Arroyo S, Joven J, Miranda-Carús ME, González-Álvaro I, Puig-Kröger A.

Ann Rheum Dis. 2016 Dec;75(12):2157-2165. doi: 10.1136/annrheumdis-2015-208736.

PMID:
26920997
10.

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.

Seoane IV, Ortiz AM, Piris L, Lamana A, Juarranz Y, García-Vicuña R, González-Álvaro I, Gomariz RP, Martínez C.

PLoS One. 2016 Feb 16;11(2):e0149141. doi: 10.1371/journal.pone.0149141.

11.

VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.

Pérez-García S, Carrión M, Gutiérrez-Cañas I, González-Álvaro I, Gomariz RP, Juarranz Y.

J Cell Mol Med. 2016 Apr;20(4):678-87. doi: 10.1111/jcmm.12777.

12.

Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.

Julià A, Blanco F, Fernández-Gutierrez B, González A, Cañete JD, Maymó J, Alperi-López M, Olivè A, Corominas H, Martínez-Taboada V, González-Álvaro I, Fernandez-Nebro A, Erra A, Sánchez-Fernández S, Alonso A, López-Lasanta M, Tortosa R, Codó L, Lluis Gelpi J, García-Montero AC, Bertranpetit J, Absher D, Myers RM, Tornero J, Marsal S.

Arthritis Rheumatol. 2016 Jun;68(6):1384-91. doi: 10.1002/art.39591.

PMID:
26815016
13.

The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression.

Lamana A, López-Santalla M, Castillo-González R, Ortiz AM, Martín J, García-Vicuña R, González-Álvaro I.

PLoS One. 2015 Nov 16;10(11):e0142683. doi: 10.1371/journal.pone.0142683.

14.

PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.

Rodriguez-Rodriguez L, Ivorra-Cortes J, Carmona FD, Martín J, Balsa A, van Steenbergen HW, van der Helm-van Mil AH, González-Álvaro I, Fernandez-Gutiérrez B.

Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.

15.

Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis.

Lopez-Lasanta M, Julià A, Maymó J, Fernández-Gutierrez B, Ureña-Garnica I, Blanco FJ, Cañete JD, Alperi-López M, Olivè A, Corominas H, Tornero J, Erra A, Almirall M, Palau N, Ortiz A, Avila G, Rodriguez-Rodriguez L, Alonso A, Tortosa R, Gonzalez-Alvaro I, Marsal S.

Arthritis Res Ther. 2015 Sep 4;17:242. doi: 10.1186/s13075-015-0737-8.

16.

[Rheumatoid arthritis at present].

González-Álvaro I, García-Vicuña R.

Med Clin (Barc). 2016 Feb 5;146(3):112-4. doi: 10.1016/j.medcli.2015.06.004. Spanish. No abstract available.

PMID:
26228258
17.

2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.

Sanmartí R, García-Rodríguez S, Álvaro-Gracia JM, Andreu JL, Balsa A, Cáliz R, Fernández-Nebro A, Ferraz-Amaro I, Gómez-Reino JJ, González-Álvaro I, Martín-Mola E, Martínez-Taboada VM, Ortiz AM, Tornero J, Marsal S, Moreno-Muelas JV.

Reumatol Clin. 2015 Sep-Oct;11(5):279-94. doi: 10.1016/j.reuma.2015.05.001. English, Spanish.

18.

Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.

Avila-Pedretti G, Tornero J, Fernández-Nebro A, Blanco F, González-Alvaro I, Cañete JD, Maymó J, Alperiz M, Fernández-Gutiérrez B, Olivé A, Corominas H, Erra A, Aterido A, López Lasanta M, Tortosa R, Julià A, Marsal S.

PLoS One. 2015 Apr 7;10(4):e0122088. doi: 10.1371/journal.pone.0122088.

19.

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity.

Seoane IV, Tomero E, Martínez C, Garcia-Vicuña R, Juarranz Y, Lamana A, Ocón E, Ortiz AM, Gómez-León N, González-Álvaro I, Gomariz RP.

J Mol Neurosci. 2015 Jul;56(3):577-84. doi: 10.1007/s12031-015-0517-6.

20.

Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.

Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S.

Rheumatol Int. 2015 Mar;35(3):445-58. doi: 10.1007/s00296-014-3196-7. Review.

PMID:
25543267
Items per page

Supplemental Content

Loading ...
Support Center